Innovations in Clinical Neuroscience | A peer-reviewed journal providing evidence-based information

The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II—Ethical Considerations Related to the Individual Participant

December 2009

by David Feifel, MD, PhD

Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California


This is protected content.
:
:
Content Protected by SmartLogix

Posted in Research to Practice | No Comments »

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.